Azzad Asset Management’s Genmab GMAB Stock Holding History

Azzad Asset Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-47,713	Closed	-$1.68M	–	311
2023 Q3	$1.68M	Hold	47,713	–	–	0.24%	166
2023 Q2	$1.81M	Hold	47,713	–	–	0.24%	157
2023 Q1	$1.8M	Hold	47,713	–	–	0.26%	159
2022 Q4	$2.02M	Buy	47,713 +432	+0.9%	+$17.8K	0.32%	126
2022 Q3	$1.52M	Hold	47,281	–	–	0.15%	197
2022 Q2	$1.54M	Hold	47,281	–	–	0.15%	201
2022 Q1	$1.71M	Buy	47,281 +2	+0%	+$69	0.25%	161
2021 Q4	$1.87M	Sell	47,279 -1	-0%	-$42	0.25%	157
2021 Q3	$2.07M	Buy	47,280 +3	+0%	+$135	0.31%	131
2021 Q2	$1.93M	Sell	47,277 -4	-0%	-$154	0.29%	148
2021 Q1	$1.55M	Buy	47,281 +23,424	+98%	+$881K	0.26%	160
2020 Q4	$970K	Buy	+23,857	New	+$892K	0.18%	193

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Azzad Asset Management's GMAB Position: Q4 2023 in Review

Azzad Asset Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 47,713 shares — an estimated $1.68M sold.

Azzad Asset Management first reported a position in GMAB in Q4 2020 and held it in 12 quarters. The position peaked at $2.07M in Q3 2021. 226 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

Azzad Asset Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
Azzad Asset Management sold 47,713 Genmab shares in Q4 2023, an estimated $1.68M.
Azzad Asset Management first reported a position in Genmab in Q4 2020 and held it in 12 quarters.
Azzad Asset Management's Genmab position peaked at $2.07M in Q3 2021.
226 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Azzad Asset Management's 13F filing for Q4 2023, filed 1 Apr 2024.